BNP Paribas Arbitrage SA cut its stake in Aetna Inc. (NYSE:AET) by 54.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,751 shares of the company’s stock after selling 34,783 shares during the period. BNP Paribas Arbitrage SA’s holdings in Aetna were worth $3,319,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hartford Financial Management Inc. increased its position in shares of Aetna by 304.8% in the second quarter. Hartford Financial Management Inc. now owns 850 shares of the company’s stock valued at $101,000 after buying an additional 640 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of Aetna by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 829 shares of the company’s stock valued at $101,000 after buying an additional 73 shares during the last quarter. Acrospire Investment Management LLC increased its position in shares of Aetna by 37.3% in the second quarter. Acrospire Investment Management LLC now owns 1,105 shares of the company’s stock valued at $135,000 after buying an additional 300 shares during the last quarter. FirstMerit Bank N A Trustee purchased a new position in shares of Aetna during the second quarter valued at approximately $200,000. Finally, Genesee Valley Trust Co. purchased a new position in shares of Aetna during the second quarter valued at approximately $203,000. 88.28% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna Inc. (NYSE:AET) traded up 2.84% during trading on Tuesday, reaching $132.03. 2,914,015 shares of the company’s stock traded hands. Aetna Inc. has a one year low of $92.42 and a one year high of $132.57. The company has a 50 day moving average of $115.34 and a 200 day moving average of $116.60. The firm has a market cap of $46.33 billion, a price-to-earnings ratio of 19.04 and a beta of 0.54.

Aetna (NYSE:AET) last released its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $2.02 by $0.05. Aetna had a return on equity of 16.25% and a net margin of 3.91%. The business earned $15.78 billion during the quarter, compared to the consensus estimate of $15.71 billion. During the same period last year, the company earned $1.90 earnings per share. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities research analysts predict that Aetna Inc. will post $8.02 EPS for the current year.

WARNING: This article was posted by Daily Political and is the propert of of Daily Political. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international copyright law. The original version of this article can be accessed at http://www.dailypolitical.com/2016/11/29/aetna-inc-aet-stake-decreased-by-bnp-paribas-arbitrage-sa.html.

Several research analysts recently commented on AET shares. Evercore ISI started coverage on shares of Aetna in a research note on Thursday, September 22nd. They issued a “buy” rating and a $128.00 target price on the stock. Leerink Swann reaffirmed a “buy” rating and issued a $135.00 target price on shares of Aetna in a research note on Thursday, August 4th. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $128.00 price objective on the stock in a research report on Tuesday, October 4th. Barclays PLC reissued a “buy” rating and set a $142.00 price objective on shares of Aetna in a research report on Monday, November 7th. Finally, FBR & Co reissued a “hold” rating and set a $135.00 price objective on shares of Aetna in a research report on Thursday, August 4th. Seven equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Aetna currently has an average rating of “Buy” and a consensus price target of $132.14.

In other news, Director Jeffrey E. Garten sold 7,100 shares of the firm’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total transaction of $827,221.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.